Wiesneth M
Abteilung für Transfusionsmedizin der Universität Ulm, BRD.
Beitr Infusionsther. 1993;31:86-91.
Worldwide, platelet transfusions have increased substantially, especially in hematological patients. The prophylactic and therapeutic indications for platelet substitution as well as the choice of platelet preparation are discussed for patients with acute leukemia or aplastic anemia who need the highest platelet support. Here we present our current strategy, i.e., prophylactic transfusions with random platelets in acute leukemia and therapeutic transfusions with filtered random platelets in aplastic anemia patients only.
在全球范围内，血小板输注量大幅增加，尤其是在血液学患者中。对于需要最高血小板支持的急性白血病或再生障碍性贫血患者，讨论了血小板替代的预防性和治疗性指征以及血小板制剂的选择。在此，我们介绍我们目前的策略，即在急性白血病中采用随机血小板进行预防性输注，而仅在再生障碍性贫血患者中采用过滤随机血小板进行治疗性输注。
